Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03410693 |
|---|---|
| Brief Title: | Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma (FORT-1) |
| First Submitted : | January 19, 2018 |
| First Submitted that Met QC Criteria : | January 19, 2018 |
| First Posted : | January 25, 2018 |
| Results First Submitted : | October 13, 2021 |
| Results First Posted with QC Comments : | November 11, 2021 |
| Results First Submitted that Met QC Criteria : | November 30, 2021 |
| Results First Posted : | December 29, 2021 |
| Last Update Submitted that Met QC Criteria : | September 25, 2022 |
| Last Update Posted : | September 28, 2022 |